Peptide YY (Human, 1-36)
PYY1-36
Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2
4528-v 0.5mg | 345.00 EUR
(M.W. 4309.8) | C194H295N55 O57 |
Synthetic Product
Purity: ≧95.0% (HPLC), Solubility: H2O (0.1 mM)
Peptididic Precursor of PYY3-36 with Antimicrobial Activity
References:
- K. Tatemoto, I. Nakano, G. Makk, P. Angwin, M. Mann, J. Schilling and V.L.W. Go, Biochem. Biophys. Res. Commun., 157, 713 (1988) (original)
- I. Vouldoukis, Y. Shai, P. Nicolas and A. Mor, FEBS. Lett., 380, 237 (1996) (in vitro antimicrobial activity)
- G.H. Ballantyne, Obes. Surg., 16, 651 (2006) (Review, appetite regulator)
- S.J. Persaud and G.A. Bewick, Diabetologia., 57, 1762 (2014) (Review)
- J.F. Pierre, B.M. Peters, D. La Torre, A.M. Sidebottom, Y. Tao, X. Zhu, C.M. Cham, L. Wang, A. Kambal, K.G. Harris, J.F. Silva, O. Zaborina, J.C. Alverdy, H. Herzog, J. Witchley, S.M. Noble, V.A. Leone, and E.B. Chang, Science, 381, 502 (2023) (in vitro antimicrobial activity contributing maintenance of gut microbiota)
For Laboratory use only! Not for Drug Use!